Synapse - Find an Expert

5608 Results

Immune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas

Meeting Abstract

Boileve, A.; Carlo, M.; Barthelemy, P.; Oudard, S.; Borchiellini, D.; Voss, M.; George, S.; Chevreau, C.; Landman-Parker, J.; Tabone, M. D.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

A Phase III, randomized, double-blind, multicenter study of adjuvant nivolumab vs placebo in patients (pts) with high-risk invasive urothelial carcinoma (UC; CheckMate 274)

Meeting Abstract

Bajorin, D.; Galsky, M. D.; Gschwend, J. E.; Tomita, Y.; Azrilevich, A.; Witjes, F.
Annals of Oncology (2017)

Fulltext@MSK | Save

Impact of cisplatin-based therapy on long-term survival in advanced urinary tract cancer (aUTC). A retrospective international study of invasive/advanced cancer of the urothelium (RISC)

Meeting Abstract

Bamias, A.; Tzannis, K.; Bamia, C.; Harshman, L. C.; Crabb, S.; Wong, Y. N.; Pal, S. K.; De Giorgi, U.; Ladoire, S.; Agarwal, N.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Mixing, matching and modifying the prostate cancer microenvironment

Journal Article

Slovin, S. F.
Translational Cancer Research (2017)

Fulltext@MSK | Save

Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting

Journal Article

Miyahira, A. K.; Cheng, H. H.; Abida, W.; Ellis, L.; Harshman, L. C.; Spratt, D. E.; Simons, J. W.; Pienta, K. J.; Soule, H. R.
Prostate (2017)

Fulltext@MSK | Save

Activating mutation of PDGFRB gene in a rare cardiac undifferentiated intimal sarcoma of the left atrium: A case report

Journal Article

Fu, X.; Niu, W.; Li, J.; Kiliti, A. J.; Al-Ahmadie, H. A.; Iyer, G.; Gao, S. P.; Li, Q.
Oncotarget (2017)

Fulltext@MSK | Save

Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases

Journal Article

Shady, W.; Petre, E. N.; Vakiani, E.; Ziv, E.; Gonen, M.; Brown, K. T.; Kemeny, N. E.; Solomon, S. B.; Solit, D. B.; Sofocleous, C. T.
Oncotarget (2017)

Fulltext@MSK | Save

Phenotypic heterogeneity of circulating tumor cells informs clinical decisions between AR signaling inhibitors and taxanes in metastatic prostate cancer

Journal Article

Scher, H. I.; Graf, R. P.; Schreiber, N. A.; McLaughlin, B.; Jendrisak, A.; Wang, Y.; Lee, J.; Greene, S.; Krupa, R.; Lu, D.; more...
Cancer Research (2017)

Fulltext@MSK | Save

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)